Erratum: Compartment-specific gene regulation of the car inducer efavirenz in vivo (Clinical Pharmacology and Therapeutics (2012) 92 (103-111) DOI: 10.1038/clpt.2012.34);Compartment-specific gene regulation of the CAR inducer efavirenz in vivo

Clinical Pharmacology and Therapeutics

Volumn 92, Issue 1, 2012, Pages 103-111

  Meyer Zu Schwabedissen, H E ^a   Oswald, S ^a   Bresser, C ^a   Nassif, A ^a   Modess, C ^a   Desta, Z ^b   Ogburn, E T ^b   Marinova, M ^c   Lutjohann D ^c   Spielhagen, C ^a   Nauck, M ^a   Kroemer, H K ^a   Siegmund, W ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4BETA HYDROXYCHOLESTEROL; BILIRUBIN; CHOLESTEROL DERIVATIVE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 2B6; EFAVIRENZ; EZETIMIBE; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CELL TYPE; DRUG BLOOD LEVEL; DUODENUM BIOPSY; GASTROINTESTINAL TRACT; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; LIVER METABOLISM; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84862591111     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.213     Document Type: Erratum

References (50)

1. Lehmann, J.M., McKee, D.D., Watson, M.A., Willson, T.M., Moore, J.T. & Kliewer, S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016-1023 (1998).
2. Goodwin, B., Moore, L.B., Stoltz, C.M., McKee, D.D. & Kliewer, S.A. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol. Pharmacol. 60, 427-431 (2001).
3. Gerbal-Chaloin, S., Daujat, M., Pascussi, J.M., Pichard-Garcia, L., Vilarem, M.J. &Maurel, P. Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J. Biol. Chem. 277, 209-217 (2002).
4. Gardner-Stephen, D. et al. Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab. Dispos. 32, 340-347 (2004).
5. Sugatani, J. et al. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem. Pharmacol. 67, 989-1000 (2004).
6. Sonoda, J., Xie, W., Rosenfeld, J.M., Barwick, J.L., Guzelian, P.S. & Evans, R.M. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc. Natl. Acad. Sci. USA 99, 13801-13806 (2002).
7. Alnouti, Y. & Klaassen, C.D. Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J. Pharmacol. Exp. Ther. 324, 612-621 (2008).
8. Meyer Zu Schwabedissen, H.E., Tirona, R.G., Yip, C.S., Ho, R.H. & Kim, R.B. Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer. Res. 68, 9338-9347 (2008).
9. Geick, A., Eichelbaum, M. & Burk, O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276, 14581-14587 (2001).
10. Wang, H. & LeCluyse, E.L. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clin. Pharmacokinet. 42, 1331-1357 (2003).
11. Moore, L.B. et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA 97, 7500-7502 (2000).
12. Borrelli, F. & Izzo, A.A. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J. 11, 710-727 (2009).
13. Burk, O., Arnold, K.A., Geick, A., Tegude, H. & Eichelbaum, M. A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol. Chem. 386, 503-513 (2005).
14. Gerbal-Chaloin, S., Daujat, M., Pascussi, J.M., Pichard-Garcia, L., Vilarem, M.J. &Maurel, P. Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J. Biol. Chem. 277, 209-217 (2002).
15. Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P. & Negishi, M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274, 6043-6046 (1999).
16. Sugatani, J. et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33, 1232-1238 (2001).
17. Smirlis, D., Muangmoonchai, R., Edwards, M., Phillips, I.R. & Shephard, E.A. Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics. J. Biol. Chem. 276, 12822-12826 (2001).
18. Baes, M., Gulick, T., Choi, H.S., Martinoli, M.G., Simha, D. & Moore, D.D. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 14, 1544-1552 (1994).
19. Maglich, J.M. et al. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278, 17277-17283 (2003).
20. Kobayashi, K. et al. Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab. Dispos. 33, 924-929 (2005).
21. Faucette, S.R. et al. Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J. Pharmacol. Exp. Ther. 320, 72-80 (2007).
22. Ngaimisi, E. et al. Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients. Clin. Pharmacol. Ther. 88, 676-684 (2010).
23. Gerber, J.G. et al.; AIDS Clinical Trials Group A5108 Team. Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. J. Acquir. Immune Defic. Syndr. 39, 307-312 (2005).
24. Diczfalusy, U., Kanebratt, K.P., Bredberg, E., Andersson, T.B., Böttiger, Y. &Bertilsson, L. 4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin. Br. J. Clin. Pharmacol. 67, 38-43 (2009).
25. Oswald, S. et al. Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteers. Clin. Pharmacol.Ther. 91, 506-513 (2012).
26. Almond, L.M., Hoggard, P.G., Edirisinghe, D., Khoo, S.H. & Back, D.J. Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals. J. Antimicrob. Chemother. 56, 738-744 (2005).
27. Siest, G. et al. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab. Dispos. 36, 182-189 (2008).
28. Manceau, S. et al. Lack of P-glycoprotein induction by rifampicin and phenobarbital in human lymphocytes. Int. J. Pharm. 395, 98-103 (2010).
29. Goodwin, B. & Moore, J.T. CAR: detailing new models. Trends Pharmacol. Sci. 25, 437-441 (2004).
30. Chandler, B. et al. The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro. J. Acquir. Immune Defic. Syndr. 33, 551-556 (2003).
31. Janneh, O. et al. Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes. J. Antimicrob. Chemother. 64, 1002-1007 (2009).
32. Burhenne, J. et al. No evidence for induction of ABC transporters in peripheral blood mononuclear cells in humans after 14 days of efavirenz treatment. Antimicrob. Agents Chemother. 54, 4185-4191 (2010).
33. Wyen, C. et al.; German Competence Network for HIV/AIDS Coordinators. Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenzcontaining regimens. J. Antimicrob. Chemother. 66, 2092-2098 (2011).
34. Albermann, N. et al. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem. Pharmacol. 70, 949-958 (2005).
35. Berruet, N., Sentenac, S., Auchere, D., Gimenez, F., Farinotti, R. & Fernandez, C. Effect of efavirenz on intestinal p-glycoprotein and hepatic p450 function in rats. J. Pharm. Pharm. Sci. 8, 226-234 (2005).
36. Mouly, S. et al. Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans. Clin. Pharmacol. Ther. 72, 1-9 (2002).
37. Wei, P., Zhang, J., Dowhan, D.H., Han, Y. & Moore, D.D. Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J. 2, 117-126 (2002).
38. Wang, X., Sykes, D.B. & Miller, D.S. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. Mol. Pharmacol. 78, 376-383 (2010).
39. Weiss, J., Herzog, M., König, S., Storch, C.H., Ketabi-Kiyanvash, N. & Haefeli, W.E. Induction of multiple drug transporters by efavirenz. J. Pharmacol. Sci. 109, 242-250 (2009).
40. Störmer, E., von Moltke, L.L., Perloff, M.D. & Greenblatt, D.J. Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture. Pharm. Res. 19, 1038-1045 (2002).
41. Auerbach, S.S., Ramsden, R., Stoner, M.A., Verlinde, C., Hassett, C. & Omiecinski, C.J. Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res. 31, 3194-3207 (2003).
42. Jinno, H. et al. Identification of novel alternative splice variants of human constitutive androstane receptor and characterization of their expression in the liver. Mol. Pharmacol. 65, 496-502 (2004).
43. Chen, T. et al. A single amino acid controls the functional switch of human constitutive androstane receptor (CAR) 1 to the xenobiotic-sensitive splicing variant CAR3. J. Pharmacol. Exp. Ther. 332, 106-115 (2010).
44. Smith, P.F., DiCenzo, R. & Morse, G.D. Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors. Clin. Pharmacokinet. 40, 893-905 (2001).
45. Lamba, J.K. et al. Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J. Pharmacol. Exp. Ther. 311, 811-821 (2004).
46. Arnold, K.A., Eichelbaum, M. & Burk, O. Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl. Recept. 2, 1 (2004).
47. Giessmann, T. et al. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clin. Pharmacol. Ther. 76, 192-200 (2004).
48. Doumas, B.T. & Wu, T.W. The measurement of bilirubin fractions in serum. Crit. Rev. Clin. Lab. Sci. 28, 415-445 (1991).
49. Lütjohann, D. et al. 4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. Int. J. Clin. Pharmacol. Ther. 47, 709-715 (2009).
50. Schmittgen, T.D. & Livak, K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108 (2008).